Plasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
-
Vasile Mircea ZĂGREANU
,
Dana POP
,
Mihnea ZDRENGHEA
,
Adela SITAR-TAUT
,
Bogdan CALOIAN
,
Dumitru Tudor ZDRENGHEA
Abstract
Plasmatic Levels of N-terminal Pro-BNP in Elderly Patients with Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) (2012). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J, 33(14):1750–7.
Richards M, Di Somma S, Mueller C, et al (2013). Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in Acute Heart Failure). JACC Heart Fail, 1(3):192-9.
Shin DI, Jaekel K, Schley P, et al (2005). Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol, 94(12):795-800.
Doust JA, Pietrzak E, Dobson A, Glasziou P (2005). How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ, 330(7492):625.
Patton KK, Heckbert SR, Alonso A, Bahrami H, Lima JA, Burke G, Kronmal RA (2013). N-terminal pro-B-type natriuretic peptide as a predictor of incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis: the effects of age, sex, and ethnicity. Heart, 99(24):1832-6.
Rossi A, Enriquez-Sarano M, Burnett JC Jr, Lerman A, Abel MD, Seward JB (2000). Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study. J Am Coll Cardiol, 35(5):1256-1262.
| Files | ||
| Issue | Vol 46 No 4 (2017) | |
| Section | Letter to the Editor | |
| Keywords | ||
| No keywords## | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
